Baseline C-reactive protein level as a predictor of mortality in bacteraemia patients: A population-based cohort study

Clinical Microbiology and Infection

Volumn 17, Issue 4, 2011, Pages 627-632

  Gradel, K O ^a,b,c,d   Thomsen, R W ^c   Lundbye Christensen, S ^b   Nielsen, H ^a   Schonheyder H C ^b  

^a Department of Infectious Diseases ^*  (Denmark)

^b AALBORG UNIVERSITY HOSPITAL   (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Bacteraemia; C reactive protein; Mortality; Prognosis; Sepsis

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; BACTEREMIA; COMORBIDITY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPULATION RESEARCH; PREDICTOR VARIABLE; PRIORITY JOURNAL;

EID: 79952716027     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2010.03284.x     Document Type: Article

References (22)

1. Povoa P. C-reactive protein: a valuable marker of sepsis. Intensive Care Med 2002; 28: 235-243.
2. Povoa P, Coelho L, Almeida E et al. Pilot study evaluating C-reactive protein levels in the assessment of response to treatment of severe bloodstream infection. Clin Infect Dis 2005; 40: 1855-1857.
3. Povoa P, Coelho L, Almeida E et al. C-reactive protein as a marker of ventilator-associated pneumonia resolution: a pilot study. Eur Respir J 2005; 25: 804-812.
4. Presterl E, Staudinger T, Pettermann M et al. Cytokine profile and correlation to the APACHE III and MPM II scores in patients with sepsis. Am J Respir Crit Care Med 1997; 156: 825-832.
5. Coelho L, Povoa P, Almeida E et al. Usefulness of C-reactive protein in monitoring the severe community-acquired pneumonia clinical course. Crit Care 2007; 11: R92.
6. Seppa Y, Bloigu A, Honkanen PO, Miettinen L, Syrjala H. Severity assessment of lower respiratory tract infection in elderly patients in primary care. Arch Intern Med 2001; 161: 2709-2713.
7. Chalmers JD, Singanayagam A, Hill AT. C-reactive protein is an independent predictor of severity in community-acquired pneumonia. Am J Med 2008; 121: 219-225.
8. Gradel KO, Søgaard M, Dethlefsen C, Nielsen H, Schønheyder HC. Magnitude of bacteraemia is a predictor of mortality during 1 year of follow-up. Epidemiol Infect 2008; 137: 94-101.
9. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-383.
10. Hosmer DW Jr, Lemeshow S. Model development. In: Hosmer DW Jr, Lemeshow S, eds. Applied survival analysis, 1st edn. New York: Wiley, 1999; 158-195.
11. Harrell FE, ed. Regression modeling strategies with applications to linear models, logistic regression and survival analysis, 1st edn. New York: Springer-Verlag, 2001.
12. Royston P, Ambler G, Sauerbrei W. The use of fractional polynomials to model continuous risk variables in epidemiology. Int J Epidemiol 1999; 28: 964-974.
13. Hedlund J, Hansson LO. Procalcitonin and C-reactive protein levels in community-acquired pneumonia: correlation with etiology and prognosis. Infection 2000; 28: 68-73.
14. Örtqvist A, Hedlund J, Wretlind B, Carlström A, Kalin M. Diagnostic and prognostic value of interleukin-6 and C-reactive protein in community-acquired pneumonia. Scand J Infect Dis 1995; 27: 457-462.
15. Menendez R, Martinez R, Reyes S et al. Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia. Thorax 2009; 64: 587-591.
16. Söderquist B, Sundqvist KG, Jones I, Holmberg H, Vikerfors T. Interleukin-6, C-reactive protein, lactoferrin and white blood cell count in patients with S. aureus septicemia. Scand J Infect Dis 1995; 27: 375-380.
17. Royston P, Altman DG, Sauerbrei W. Dichotomizing continuous predictors in multiple regression: a bad idea. Stat Med 2006; 25: 127-141.
18. Leibovici L, Samra Z, Konigsberger H, Drucker M, Ashkenazi S, Pitlik SD. Long-term survival following bacteremia or fungemia. JAMA 1995; 274: 807-812.
19. Pedersen G, Schønheyder HC, Sørensen HT. Source of infection and other factors associated with case fatality in community-acquired bacteremia-a Danish population-based cohort study from 1992 to 1997. Clin Microbiol Infect 2003; 9: 793-802.
20. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340: 448-454.
21. Pedersen CB, Gøtzsche H, Møller JO, Mortensen PB. The Danish Civil Registration System. A cohort of eight million persons. Dan Med Bull 2006; 53: 441-449.
22. Leibovici L, Shraga I, Drucker M, Konigsberger H, Samra Z, Pitlik SD. The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med 1998; 244: 379-386.